Home > Healthcare > Medical Devices > Surgical Devices > Tissue Expanders Market
Tissue Expanders Market size is projected to expand at substantial CAGR from 2024 to 2032. The rising occurrence of breast reconstruction surgeries, due to the growing prevalence of breast cancer in women across the globe is fueling the demand for tissue expanders. The increasing popularity of cosmetic surgeries for face, neck, lips, and breast implants is driving the emergence of reconstruction procedures for congenital deformities.
Moreover, the influx of R&D initiatives to facilitate innovative and technologically advanced products. However, potential complications and the rising risks associated with surgeries, high costs, and limited reimbursement policies may hinder the market expansion to some extent.
The increased focus on digital technologies for customization benefits is leading to the development of patient-specific expanders and innovations in materials for enhanced compatibility. The growing adoption of remote monitoring and patient engagement solutions is another rising trend in the tissue expander market. The growing awareness about aesthetic and reconstructive procedures is resulting in favorable reimbursement policies and healthcare infrastructure development.
According to American Cancer Society, over 310,720 new cases of invasive breast cancer will be diagnosed in women across the U.S. in 2024 with around 56,500 new cases accounting for ductal carcinoma. Likewise, breast cancer could result in the mortality of over 42,250 women in 2024. This trend is likely to escalate the demand for tissue expanders in the forecasted timeline.
The anatomical shape segment is projected to witness significant CAGR between 2024 and 2032, due to the rising demand for natural-looking breast reconstructions. Anatomically shaped expanders offer a more natural appearance, leading to their increasing adoption in breast reconstruction procedures. Moreover, the growing emphasis on aesthetics and patient satisfaction.
In terms of application, the market value from the oral and maxillofacial reconstruction application segment is anticipated to rise substantially through 2032. The progression is owing to the increasing use of tissue expanders in reconstructive surgeries of the oral cavity, face, mouth, jaws, head and neck, facial trauma, and cosmetic surgeries. Additionally, the surge in face deformities due to accidents and burn-related cases will also fuel the product demand.
The North America tissue expanders market size is projected to depict substantial CAGR from 2024 to 2032. The development can be attributed to the rising number of cosmetic and reconstructive surgeries, advancements in healthcare infrastructure, and increased awareness about breast reconstruction options. The rise in product approvals will also favor the market expansion. For example, in March 2022, Health Canada approved Sientra Inc.'s smooth surface, high-strength cohesive (HSC and HSC+) silicone gel breast implants for marketing in Canada. The growing incidence of breast cancer and the heightened attention from market players in North America will also drive the market expansion.
Some of the major tissue expanders companies are:
Leading firms operating in the tissue expanders industry are engaged in various development strategies, including new product developments, capacity expansions and partnerships, to strengthen their market footprint across the globe. For instance, GC aesthetics a leading multinational European breast implant manufacturer, is rigorously empowering and supporting individuals in their body transformation journey.